Electrophysiological effects of sodium channel blockers on guinea pig left atrium.
The electrophysiological effects of five sodium channel blockers (mexiletine, lidocaine, disopyramide, aprindine and flecainide) on the guinea pig left atrium were investigated by recording the action potential and its maximum rate of rise (Vmax). The onset and offset kinetics of use-dependent block of Vmax were analyzed. Lidocaine, aprindine and flecainide were classified clearly as fast, intermediate and slow, respectively. Mexiletine and disopyramide had two components in onset and offset of use-dependent block. Mexiletine showed fast and intermediate kinetics, whereas disopyramide showed intermediate and slow kinetics. Action potential duration at 90% repolarization (APD) was prolonged by disopyramide and mexiletine. The other drugs did not change the action potential duration. Effective refractory period was prolonged by all drugs with relative potency in the following order: disopyramide greater than mexiletine greater than lidocaine greater than aprindine = flecainide. In conclusion, the modes of actions of sodium channel blockers on the atrium were disclosed to be different from those on the ventricle. The pharmacological therapy for atrial arrhythmias should be based on the electrophysiological effects of the drugs on the atrium, not on the ventricle.
Shirayama
T
T
Kyoto Prefectural University of Medicine, Second Department of Medicine, Japan.
Inoue
D
D
Inoue
M
M
Tatsumi
T
T
Yamahara
Y
Y
Asayama
J
J
Katsume
H
H
Nakagawa
M
M
D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology; D001073:Aprindine / Q000494:pharmacology; D016275:Atrial Function; D016279:Atrial Function, Left / Q000187:drug effects; D003971:Diastole / Q000187:drug effects / Q000502:physiology; D004206:Disopyramide / Q000494:pharmacology; D004594:Electrophysiology; D005260:Female; D005424:Flecainide / Q000494:pharmacology; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects* / Q000502:physiology; D006325:Heart Atria / Q000187:drug effects; D007700:Kinetics; D008012:Lidocaine / Q000494:pharmacology; D008297:Male; D015222:Sodium Channels / Q000187:drug effects*
D000889:Anti-Arrhythmia Agents; D015222:Sodium Channels; D001073:Aprindine; D008012:Lidocaine; D004206:Disopyramide; D005424:Flecainide